Soluble TREM2 cleaved from the surface of microglia has been proposed as a biomarker in other neurological diseases including Alzheimer’s disease and multiple sclerosis [20, 34, 36, 47]. Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.